PointState Capital
GCVRZ

PointState Capital’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

PointState Capital’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-7,305,164
Closed -$3.29M – 194
2017
Q1 		$3.29M Hold
7,305,164
– – 0.03% 119
2016
Q4 		$2.78M Buy
+7,305,164
New +$2.47M 0.04% 106

Other funds holding GCVRZ

SCM
Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return
Elliott Management
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
MCM
Mason Capital Management New York $607M AUM 1.77% 1-Year Est. Return
TPG Group Holdings (SBS) Advisors
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Brigade Capital Management
Brigade Capital Management New York $534M AUM 44.37% 1-Year Est. Return
Whitebox Advisors
Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
Highbridge Capital Management
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return

PointState Capital's GCVRZ Position: Q2 2017 in Review

PointState Capital sold out of Sanofi Contingent Value Rights (GCVRZ) in Q2 2017, closing a stake of 7,305,164 shares — an estimated $3.29M sold.

PointState Capital first reported a position in GCVRZ in Q4 2016 and held it in 2 quarters. The position peaked at $3.29M in Q1 2017. 115 funds tracked by Wall St. Rank hold GCVRZ as of Q2 2017.

  • PointState Capital reported no remaining Sanofi Contingent Value Rights position as of Q2 2017 after selling out during the quarter.
  • PointState Capital sold 7,305,164 Sanofi Contingent Value Rights shares in Q2 2017, an estimated $3.29M.
  • PointState Capital first reported a position in Sanofi Contingent Value Rights in Q4 2016 and held it in 2 quarters.
  • PointState Capital's Sanofi Contingent Value Rights position peaked at $3.29M in Q1 2017.
  • 115 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q2 2017.

Based on PointState Capital's 13F filing for Q2 2017, filed 14 Aug 2017.